Biodexa Pharmaceuticals Plc - ADR
BDRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.59M
Close$
$0.02
98.8% downside
Current Fair Value
98.8% downsideOvervalued by 98.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.59 Million |
|---|---|
| Enterprise Value | $-6,868,886.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-80 |
| Beta | 1.21 |
| Outstanding Shares | 451,635 |
Return
| Return on Equity | -91.73% |
|---|---|
| Return on Assets | -57.55% |
| Return on Invested Capital | -131.59% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | -0.05 |
| Price to Sales | - |
| Price to Book Ratio | 0.07 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.43 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 24, 2026
EPS Estimate
$-0.00
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biodexa Pharmaceuticals Plc
20 employees